Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

Pawel Muranski, MD, Sarah I Davies, Sawa Ito, MD, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, Steven L Highfill, PhD, Marianna Sabatino, MD, David F. Stroncek, Minoo Battiwalla, MD, Austin John Barrett

Blood (2018) 132 (Supplement 1): 812.

https://doi.org/10.1182/blood-2018-99-119314

Published: 2018

Journal Articles

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

Prachi Jain, MD, Xin Tian, PhD, Jinguo Chen, MD, Caroline R Cantilena, Christian Bradley, Reema Panjwani, BS, Keyvan Keyvanfar, Fariba Chinian, MS, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Sara Hauffe, RN, Minoo Battiwalla, MD, A John Barrett, MD, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4509.

https://doi.org/10.1182/blood.V130.Suppl_1.4509.4509

Published: 2017

Journal Articles

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reema Panjwani, BS, Stefan Cordes, MD PhD, Zerick Terrell Dunbar, BS, MS, Jinguo Chen, MD, Prachi Jain, MD, Fariba Chinian, MS, Sara Hauffe, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Rongye Shi, MD, Huizhi Zhou, David Stroncek, MD, Nan Zhang, PhD, Sarah Davies, BS, Minoo Battiwalla, MD, Austin John Barrett, MD FRCP, FRCPath, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4472.

https://doi.org/10.1182/blood.V130.Suppl_1.4472.4472

Published: 2017

Journal Articles

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Natasha A Jain, MD, Prathima Anandi, MD, Upneet Chawla, BS, MD, Sawa Ito, MD PhD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Robert Q. Le, MD PhD, David Stroncek, MD, Pawel Muranski, MD, Minoo Battiwalla, MD MS, John Barrett, MD

Blood (2016) 128 (22): 4596.

https://doi.org/10.1182/blood.V128.22.4596.4596

Published: 2016

Journal Articles

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Pawel Muranski, MD, Greg Whitehill, BS, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, MS, Marianna Sabatino, MD, Steven L. Highfill, PhD, Hanh Khuu, MD, Sarah I Davies, Mark Chang, Upneet Chawla, BS, MD, Alexandros Spyridonidis, MD PhD, Gary Fahle, MT,SM, Sawa Ito, MD PhD, David Stroncek, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 979.

https://doi.org/10.1182/blood.V128.22.979.979

Published: 2016

Journal Articles

Distinct Biomarker Profiles in Ex-Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection Vs CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation

Caroline R. Cantilena, BA, Sawa Ito, MD PhD, Xin Tian, Prachi Jain, MD, Fariba Chinian, Prathima Anandi, MD, Upneet Chawla, BS, MD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, David Stroncek, MD, Pawel Muranski, MD, John Barrett, MD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 657.

https://doi.org/10.1182/blood.V128.22.657.657

Published: 2016

Journal Articles

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Upneet Chawla, BS, MD, Maureen Sampson, MT, Natasha A Jain, MD, Prathima Anandi, MD, Sawa Ito, MD PhD, Eleftheria Koklanaris, RN, Pawel Muranski, MD, John Barrett, MD, Marcus Y Chen, MD, Alan Remaley, MD PhD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 828.

https://doi.org/10.1182/blood.V128.22.828.828

Published: 2016

Journal Articles

Clofarabine Followed By Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia- Preliminary Clinical Outcomes and Potential Immune-Modulating Effects

Prachi Jain, MD, Sawa Ito, MD PhD, Neil Dunavin, MD, Jeffrey K. Klotz, MD, Kit Lu, MD, Eleftheria Koklanaris, RN, BSN, Debbie Draper, RN, BSN, Jeanine Superata, RN, Fariba Chinian, Quan Yu, MS, Keyvan Keyvanfar, BS, Susan Wong, Pawel Muranski, MD, John Barrett, MD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 5553.

https://doi.org/10.1182/blood.V128.22.5553.5553

Published: 2016

Journal Articles

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Dana L Shanis, MD, Prathima Anandi, MD, Caitlin Grant, Priyanka A Pophali, MD, Eleftheria Koklanaris, Bipin N. Savani, MD, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS, Pamela Stratton, MD

Blood (2015) 126 (23): 1956.

https://doi.org/10.1182/blood.V126.23.1956.1956

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Distinct Biomarker Profiles in Ex-Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection Vs CD3/19 Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Clofarabine Followed By Lenalidomide for Treatment of High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia- Preliminary Clinical Outcomes and Potential Immune-Modulating Effects

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology